홈 > 시장보고서 > 의약품

시장보고서

상품코드

1628867

세계의 생체접합 시장 : 유형별, 수법별, 제공내용별, 생체접합유형별, 용도별, 치료 영역별, 최종사용자별, 국가별, 지역별 예측(2024-2032년)

Bioconjugation Market, By Type, By Technique, By Offering, By Bioconjugation Type, By Application, By Therapeutic Area, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 11월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 398 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

생체접합 시장 규모는 2023년 51억 2,232만 달러로 2024년부터 2032년까지 15.2%의 연평균 복합 성장률(CAGR)로 확대될 것으로 예상됩니다.

생체접합 시장 역학

항체 약물 복합체(ADC) 수요 증가는 시장 수요 촉진

생체접합의 중요한 용도인 ADC는 표적을 좁힌 암 치료에 의해 높은 성장이 예상되고 있습니다. 또한 만성 질환의 치료에서 바이오 치료제의 용도 확대가 생체접합 연구를 뒷받침하고 있습니다. 그러나 첨단 생체접합 기술은 상당한 자금을 필요로 하기 때문에 중소기업의 진입은 제한되어 있습니다. 반대로, 새로운 컨쥬게이션 도구는 효율성을 향상시키고 진단 및 개인화된 의료에 대한 광범위한 응용을 촉진합니다. 게다가 자금조달 증가에 의해 연구개발이 지원되고 생체접합 시장 성장의 새로운 길이 열리고 있습니다.

생체접합 시장 : 주요 고려사항

리서치 애널리스트의 분석에 따르면 세계 시장은 예측 기간(2024-2032년)에 약 15.2%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예측되고 있습니다.

유형별로 보면 천연 생체접합이 2023년 최대 시장 점유율을 나타낼 것으로 예측됩니다.

기법별로 보면 아미드 결합 형성이 2023년 주요 유형이었습니다.

제공 내용별로 보면, 2023년에는 서비스가 주요 유형이었습니다.

생체접합유형별로 보면, 2023년에는 단백질 생체접합이 주요한 유형였습니다.

용도별로 보면 2023년의 주요 유형은 치료제였습니다.

지역별로는 북미가 2023년 매출에서 최고였습니다.

생체접합 시장 : 세분화 분석

세계의 생체접합 시장은 유형, 기법, 제공 내용, 생체접합의 유형, 용도, 치료 영역, 최종 사용자, 지역에 따라 구분됩니다.

바이오컨쥬게이트 시장은 합성 바이오컨쥬게이트와 천연 바이오컨쥬게이트의 두 가지로 분류됩니다. 생체접합 시장을 독점할 것으로 예상됩니다.

시장은 수법에 따라 아미드 결합 형성, 클릭 화학, 바이오 직교 반응, 효소법, 티올-말레이미드 커플링의 5가지로 분류됩니다.

생체접합 시장 : 지역별 분석

지역적으로, 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카의 각 지역으로 퍼져 있습니다.

생체접합 시장 : 경쟁 구도

표적 치료 및 약물전달 혁신에 대한 수요 증가에 힘입어 생체접합 시장에서는 신기술의 연구개발 투자, 용도 확대를 위한 제휴, 첨단 컨쥬게이션 기술에 의한 제품 차별화 등의 전략을 보 기업은 더 나은 효과와 안전성을 실현합니다. 이를 위해 링커와 페이로드의 최적화에 주력하고 있습니다. 종합적으로 시장 경쟁력을 높여 차세대 치료 솔루션의 개발을 가능하게 합니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제15장 주요 벤더 분석 : 생체접합 업계

경쟁 대시보드
- 경쟁 벤치마킹
- 경쟁 포지셔닝
기업 프로파일
- AbbVie Inc.
- Abcam plc
- Abzena Limited
- Agilent Technologies, Inc.
- AstraZeneca PLC
- Biocon Limited
- Bio-Techne Corporation
- Boehringer Ingelheim GmbH
- Charles River Laboratories International, Inc.
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- GlaxoSmithKline plc
- F. Hoffmann-La Roche AG
- Innovagen AB
- Lonza Group AG
- Johnson &Johnson Services Inc.
- Merck KGaA
- Sanofi SA
- Pfizer Inc.
- Sartorius AG
- Sutro Biopharma, Inc.
- Sorrento Therapeutics, Inc.
- Thermo Fisher Scientific Inc.
- WuXi AppTec Co., Ltd.
- Others

16장 AnalystView의 전방위 분석

JHS 25.01.31

REPORT HIGHLIGHT

Bioconjugation market size was valued at USD 5,122.32 Million in 2023, expanding at a CAGR of 15.2% from 2024 to 2032.

Bioconjugation is the process of chemically linking two biomolecules, such as proteins, antibodies, or nucleic acids, to enhance their functionality or specificity. This technique is widely applied in drug development, diagnostics, and imaging. By attaching therapeutic agents or markers to biomolecules, bioconjugation enables targeted delivery, improved stability, and reduced side effects. It is a cornerstone in developing antibody-drug conjugates, biosensors, and personalized medicine, significantly advancing biotherapeutics and biomedical research.

Bioconjugation Market- Market Dynamics

Rising demand for antibody-drug conjugates (ADC) growth to propel market demand

ADCs, a critical application of bioconjugation, are expected to witness strong growth due to their targeted cancer therapies. Besides, expanding applications of biotherapeutics in treating chronic diseases boost bioconjugation research. However, advanced bioconjugation techniques demand significant financial investment, limiting accessibility for smaller firms. On the contrary, novel conjugation tools improve efficiency, encouraging broader applications in diagnostics and personalized medicine. Furthermore, increasing funding supports R&D, creating new avenues for bioconjugation market growth.

Bioconjugation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.2% over the forecast period (2024-2032)

Based on type segmentation, natural bioconjugations was predicted to show maximum market share in the year 2023

Based on technique segmentation, amide bond formation was the leading type in 2023

Based on offering segmentation, services were the leading type in 2023

Based on bioconjugation type segmentation, protein bioconjugation was the leading type in 2023

Based on application segmentation, therapeutic was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Bioconjugation Market- Segmentation Analysis:

The Global Bioconjugation Market is segmented on the basis of Type, Technique, Offering, Bioconjugation Type, Application, Therapeutic Area, End User, and Region.

The market is divided into two categories based on Type: synthetic bioconjugates and natural bioconjugates. The natural bioconjugates segment is expected to dominate the bioconjugation market due to its widespread application in biologics and drug development, offering high specificity and compatibility with biological systems.

The market is divided into five categories based on Technique: amide bond formation, click chemistry, bio-orthogonal reactions, and enzymatic methods, and thiol-maleimide coupling. The amide bond formation sector dominates the market and is likely to maintain its dominance during the forecast period. This is due to its extensive use in linking biomolecules for therapeutic and diagnostic applications. Its stability and efficiency make it widely preferred.

Bioconjugation Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Bioconjugation Market- Competitive Landscape:

Driven by the increasing demand for targeted therapies and drug delivery innovations, the bioconjugation market sees strategies like R&D investments for novel technologies, partnerships to expand applications, and product differentiation through advanced conjugation techniques. Companies focus on optimizing linkers and payloads for better efficacy and safety. Additionally, the market emphasizes regulatory compliance and scaling manufacturing capabilities to meet growing demands in biopharmaceuticals and diagnostics. These strategies collectively enhance market competitiveness and enable the development of next-generation therapeutic solutions.

Recent Developments:

In November 2024, Lonza announced that it is expanding its bioconjugation facility in Visp, Switzerland, adding two 1,200 L manufacturing suites and infrastructure, creating 200 jobs. Operations are expected to begin in 2028.

In March 2024, Abzena announced that it is expanding its Bristol, PA bioconjugate manufacturing site with a $5 million investment in new equipment, upgraded facilities, and enhanced laboratory space, boosting biopharmaceutical program capacity.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOCONJUGATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

AbbVie Inc.
Abcam plc
Abzena Limited
Agilent Technologies, Inc.
AstraZeneca PLC
Biocon Limited
Bio-Techne Corporation
Boehringer Ingelheim GmbH
Charles River Laboratories International, Inc.
Bristol-Myers Squibb Company
Eli Lilly and Company
GlaxoSmithKline plc
F. Hoffmann-La Roche AG
Innovagen AB
Lonza Group AG
Johnson & Johnson Services Inc.
Merck KGaA
Sanofi S.A.
Pfizer Inc.
Sartorius AG
Sutro Biopharma, Inc.
Sorrento Therapeutics, Inc.
Thermo Fisher Scientific Inc.
WuXi AppTec Co., Ltd.
Others

GLOBAL BIOCONJUGATION MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Natural Bioconjugates
Synthetic Bioconjugates

GLOBAL BIOCONJUGATION MARKET, BY TECHNIQUE- MARKET ANALYSIS, 2019 - 2032

Amide Bond Formation
Click Chemistry
Bio-orthogonal Reactions
Thiol-Maleimide Coupling
Enzymatic Methods

GLOBAL BIOCONJUGATION MARKET, BY OFFERING- MARKET ANALYSIS, 2019 - 2032

Reagents & Kits
Services
ADC Process Development
Drug Substance Manufacturing
Analytical Development
Early Development Bioconjugate Services
Targeting Agent or Carrier Protein Services
Payload & Linker Manufacturing

GLOBAL BIOCONJUGATION MARKET, BY BIOCONJUGATION TYPE- MARKET ANALYSIS, 2019 - 2032

Oligonucleotide Bioconjugation
Single-stranded Oligonucleotides
Double-stranded Oligonucleotides
Polymer Bioconjugation
Peptide Bioconjugation
Protein Bioconjugation

GLOBAL BIOCONJUGATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Diagnostics
Therapeutic
Vaccines
Monoclonal Antibodies
Antibiotics
Research & Development

GLOBAL BIOCONJUGATION MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

Infectious Diseases
Immunology
Cardiovascular Disorders
Oncology

GLOBAL BIOCONJUGATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Biotechnology Companies
Academic & Research Institutions
Pharmaceutical Companies
Contract Research Organizations

GLOBAL BIOCONJUGATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Bioconjugation Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Bioconjugation Market Snippet by Type
- 2.1.2. Bioconjugation Market Snippet by Technique
- 2.1.3. Bioconjugation Market Snippet by Offering
- 2.1.4. Bioconjugation Market Snippet by Bioconjugation Type
- 2.1.5. Bioconjugation Market Snippet by Application
- 2.1.6. Bioconjugation Market Snippet by Therapeutic Area
- 2.1.7. Bioconjugation Market Snippet by End User
- 2.1.8. Bioconjugation Market Snippet by Country
- 2.1.9. Bioconjugation Market Snippet by Region
2.2. Competitive Insights

3. Bioconjugation Key Market Trends

3.1. Bioconjugation Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Bioconjugation Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Bioconjugation Market Opportunities
3.4. Bioconjugation Market Future Trends

4. Bioconjugation Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Bioconjugation Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Bioconjugation Market Landscape

6.1. Bioconjugation Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Bioconjugation Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
- 7.1.2. Natural Bioconjugates
- 7.1.3. Synthetic Bioconjugates

8. Bioconjugation Market - By Technique

8.1. Overview
- 8.1.1. Segment Share Analysis, By Technique, 2023 & 2032 (%)
- 8.1.2. Amide Bond Formation
- 8.1.3. Click Chemistry
- 8.1.4. Bio-orthogonal Reactions
- 8.1.5. Thiol-Maleimide Coupling
- 8.1.6. Enzymatic Methods

9. Bioconjugation Market - By Offering

9.1. Overview
- 9.1.1. Segment Share Analysis, By Offering, 2023 & 2032 (%)
- 9.1.2. Reagents & Kits
- 9.1.3. Services
  - 9.1.3.1. ADC Process Development
  - 9.1.3.2. Drug Substance Manufacturing
  - 9.1.3.3. Analytical Development
  - 9.1.3.4. Early Development Bioconjugate Services
  - 9.1.3.5. Targeting Agent or Carrier Protein Services
  - 9.1.3.6. Payload & Linker Manufacturing

10. Bioconjugation Market - By Bioconjugation Type

10.1. Overview
- 10.1.1. Segment Share Analysis, By Bioconjugation Type, 2023 & 2032 (%)
- 10.1.2. Oligonucleotide Bioconjugation
  - 10.1.2.1. Single-stranded Oligonucleotides
  - 10.1.2.2. Double-stranded Oligonucleotides
- 10.1.3. Polymer Bioconjugation
- 10.1.4. Peptide Bioconjugation
- 10.1.5. Protein Bioconjugation

11. Bioconjugation Market - By Application

11.1. Overview
- 11.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 11.1.2. Diagnostics
- 11.1.3. Therapeutic
  - 11.1.3.1. Vaccines
  - 11.1.3.2. Monoclonal Antibodies
  - 11.1.3.3. Antibiotics
- 11.1.4. Research & Development

12. Bioconjugation Market - By Therapeutic Area

12.1. Overview
- 12.1.1. Segment Share Analysis, By Therapeutic Area, 2023 & 2032 (%)
- 12.1.2. Infectious Diseases
- 12.1.3. Immunology
- 12.1.4. Cardiovascular Disorders
- 12.1.5. Oncology

13. Bioconjugation Market - By End User

13.1. Overview
- 13.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
- 13.1.2. Biotechnology Companies
- 13.1.3. Academic & Research Institutions
- 13.1.4. Pharmaceutical Companies
- 13.1.5. Contract Research Organizations

14. Bioconjugation Market- By Geography

14.1. Introduction
- 14.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
14.2. North America
- 14.2.1. Overview
- 14.2.2. Bioconjugation Key Manufacturers in North America
- 14.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 14.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.2.5. North America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.2.6. North America Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.2.7. North America Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.2.8. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.2.9. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.2.10. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.2.11. U.S.
  - 14.2.11.1. Overview
  - 14.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.2.11.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.2.11.4. U.S. Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.2.11.5. U.S. Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.2.11.6. U.S. Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.2.11.7. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.2.11.8. U.S. Market Size and Forecast, By Bioconjugation Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.2.11.9. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 14.2.11.10.
- 14.2.12. Canada
  - 14.2.12.1. Overview
  - 14.2.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.2.12.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.2.12.4. Canada Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.2.12.5. Canada Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.2.12.6. Canada Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.2.12.7. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.2.12.8. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.2.12.9. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 14.2.12.10.
14.3. Europe
- 14.3.1. Overview
- 14.3.2. Bioconjugation Key Manufacturers in Europe
- 14.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 14.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.3.5. Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.3.6. Europe Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.3.7. Europe Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.3.8. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.3.9. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.3.10. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.3.11. Germany
  - 14.3.11.1. Overview
  - 14.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.3.11.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.3.11.4. Germany Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.3.11.5. Germany Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.3.11.6. Germany Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.3.11.7. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.3.11.8. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.3.11.9. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.3.12. Italy
  - 14.3.12.1. Overview
  - 14.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.3.12.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.3.12.4. Italy Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.3.12.5. Italy Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.3.12.6. Italy Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.3.12.7. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.3.12.8. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.3.12.9. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.3.13. United Kingdom
  - 14.3.13.1. Overview
  - 14.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.3.13.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.3.13.4. United Kingdom Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.3.13.5. United Kingdom Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.3.13.6. United Kingdom Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.3.13.7. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.3.13.8. United Kingdom Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.3.13.9. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.3.14. France
  - 14.3.14.1. Overview
  - 14.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.3.14.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.3.14.4. France Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.3.14.5. France Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.3.14.6. France Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.3.14.7. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.3.14.8. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.3.14.9. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.3.15. Russia
  - 14.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.3.15.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.3.15.3. Russia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.3.15.4. Russia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.3.15.5. Russia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.3.15.7. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.3.15.8. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.3.16. Netherlands
  - 14.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.3.16.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.3.16.3. Netherlands Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.3.16.4. Netherlands Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.3.16.5. Netherlands Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.3.16.6. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.3.16.7. Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.3.16.8. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.3.17. Sweden
  - 14.3.17.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.3.17.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.3.17.3. Sweden Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.3.17.4. Sweden Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.3.17.5. Sweden Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.3.17.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.3.17.7. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.3.17.8. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.3.18. Poland
  - 14.3.18.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.3.18.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.3.18.3. Poland Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.3.18.4. Poland Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.3.18.5. Poland Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.3.18.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.3.18.7. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.3.18.8. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.3.19. Rest of Europe
  - 14.3.19.1. Overview
  - 14.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.3.19.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.3.19.4. Rest of the Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.3.19.5. Rest of the Europe Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.3.19.6. Rest of the Europe Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.3.19.7. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.3.19.8. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.3.19.9. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
14.4. Asia Pacific (APAC)
- 14.4.1. Overview
- 14.4.2. Bioconjugation Key Manufacturers in Asia Pacific
- 14.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 14.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.4.5. Asia Pacific Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.4.6. Asia Pacific Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.4.7. Asia Pacific Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.4.8. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.4.9. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.4.10. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.4.11. India
  - 14.4.11.1. Overview
  - 14.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.4.11.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.4.11.4. India Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.4.11.5. India Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.4.11.6. India Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.4.11.7. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.4.11.8. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.4.11.9. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.4.12. China
  - 14.4.12.1. Overview
  - 14.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.4.12.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.4.12.4. China Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.4.12.5. China Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.4.12.6. China Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.4.12.7. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.4.12.8. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.4.12.9. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.4.13. Japan
  - 14.4.13.1. Overview
  - 14.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.4.13.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.4.13.4. Japan Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.4.13.5. Japan Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.4.13.6. Japan Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.4.13.7. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.4.13.8. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.4.13.9. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.4.14. South Korea
  - 14.4.14.1. Overview
  - 14.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.4.14.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.4.14.4. South Korea Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.4.14.5. South Korea Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.4.14.6. South Korea Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.4.14.7. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.4.14.8. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.4.14.9. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.4.15. Australia
  - 14.4.15.1. Overview
  - 14.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.4.15.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.4.15.4. Australia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.4.15.5. Australia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.4.15.6. Australia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.4.15.7. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.4.15.8. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.4.15.9. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.4.16. Thailand
  - 14.4.16.1. Overview
  - 14.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.4.16.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.4.16.4. Thailand Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.4.16.5. Thailand Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.4.16.6. Thailand Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.4.16.7. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.4.16.8. hailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.4.16.9. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.4.17. Indonesia
  - 14.4.17.1. Overview
  - 14.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.4.17.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.4.17.4. Indonesia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.4.17.5. Indonesia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.4.17.6. Indonesia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.4.17.7. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.4.17.8. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.4.17.9. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.4.18. Philippines
  - 14.4.18.1. Overview
  - 14.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.4.18.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.4.18.4. Philippines Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.4.18.5. Philippines Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.4.18.6. Philippines Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.4.18.7. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.4.18.8. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.4.18.9. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.4.19. Rest of APAC
  - 14.4.19.1. Overview
  - 14.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.4.19.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.4.19.4. Rest of APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.4.19.5. Rest of APAC Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.4.19.6. Rest of APAC Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.4.19.7. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.4.19.8. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.4.19.9. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
14.5. Latin America
- 14.5.1. Overview
- 14.5.2. Bioconjugation Key Manufacturers in Latin America
- 14.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 14.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.5.5. Latin America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.5.6. Latin America Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.5.7. Latin America Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.5.8. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.5.9. Latin America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.5.10. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.5.11. Brazil
  - 14.5.11.1. Overview
  - 14.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.5.11.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.5.11.4. Brazil Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.5.11.5. Brazil Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.5.11.6. Brazil Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.5.11.7. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.5.11.8. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.5.11.9. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.5.12. Mexico
  - 14.5.12.1. Overview
  - 14.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.5.12.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.5.12.4. Mexico Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.5.12.5. Mexico Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.5.12.6. Mexico Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.5.12.7. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.5.12.8. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.5.12.9. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.5.13. Argentina
  - 14.5.13.1. Overview
  - 14.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.5.13.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.5.13.4. Argentina Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.5.13.5. Argentina Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.5.13.6. Argentina Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.5.13.7. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.5.13.8. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.5.13.9. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.5.14. Colombia
  - 14.5.14.1. Overview
  - 14.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.5.14.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.5.14.4. Colombia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.5.14.5. Colombia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.5.14.6. Colombia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.5.14.7. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.5.14.8. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.5.14.9. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.5.15. Rest of LATAM
  - 14.5.15.1. Overview
  - 14.5.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.5.15.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.5.15.4. Rest of LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.5.15.5. Rest of LATAM Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.5.15.6. Rest of LATAM Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.5.15.7. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.5.15.8. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.5.15.9. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
14.6. Middle East and Africa
- 14.6.1. Overview
- 14.6.2. Bioconjugation Key Manufacturers in Middle East and Africa
- 14.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 14.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.6.5. Middle East and Africa Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.6.6. Middle East and Africa Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.6.7. Middle East and Africa Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.6.8. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.6.9. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.6.10. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.6.11. Saudi Arabia
  - 14.6.11.1. Overview
  - 14.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.6.11.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.6.11.4. Saudi Arabia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.6.11.5. Saudi Arabia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.6.11.6. Saudi Arabia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.6.11.7. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.6.11.8. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.6.11.9. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.6.12. United Arab Emirates
  - 14.6.12.1. Overview
  - 14.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.6.12.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.6.12.4. United Arab Emirates Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.6.12.5. United Arab Emirates Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.6.12.6. United Arab Emirates Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.6.12.7. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.6.12.8. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.6.12.9. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.6.13. Israel
  - 14.6.13.1. Overview
  - 14.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.6.13.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.6.13.4. Israel Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.6.13.5. Israel Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.6.13.6. Israel Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.6.13.7. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.6.13.8. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.6.13.9. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.6.14. Turkey
  - 14.6.14.1. Overview
  - 14.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.6.14.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.6.14.4. Turkey Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.6.14.5. Turkey Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.6.14.6. Turkey Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.6.14.7. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.6.14.8. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.6.14.9. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.6.15. Algeria
  - 14.6.15.1. Overview
  - 14.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.6.15.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.6.15.4. Algeria Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.6.15.5. Algeria Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.6.15.6. Algeria Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.6.15.7. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.6.15.8. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.6.15.9. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.6.16. Egypt
  - 14.6.16.1. Overview
  - 14.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.6.16.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.6.16.4. Egypt Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.6.16.5. Egypt Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.6.16.6. Egypt Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.6.16.7. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.6.16.8. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.6.16.9. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.6.17. Rest of MEA
  - 14.6.17.1. Overview
  - 14.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 14.6.17.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 14.6.17.4. Rest of MEA Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 14.6.17.5. Rest of MEA Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
  - 14.6.17.6. Rest of MEA Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
  - 14.6.17.7. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 14.6.17.8. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 14.6.17.9. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

15. Key Vendor Analysis- Bioconjugation Industry

15.1. Competitive Dashboard
- 15.1.1. Competitive Benchmarking
- 15.1.2. Competitive Positioning
15.2. Company Profiles
- 15.2.1. AbbVie Inc.
- 15.2.2. Abcam plc
- 15.2.3. Abzena Limited
- 15.2.4. Agilent Technologies, Inc.
- 15.2.5. AstraZeneca PLC
- 15.2.6. Biocon Limited
- 15.2.7. Bio-Techne Corporation
- 15.2.8. Boehringer Ingelheim GmbH
- 15.2.9. Charles River Laboratories International, Inc.
- 15.2.10. Bristol-Myers Squibb Company
- 15.2.11. Eli Lilly and Company
- 15.2.12. GlaxoSmithKline plc
- 15.2.13. F. Hoffmann-La Roche AG
- 15.2.14. Innovagen AB
- 15.2.15. Lonza Group AG
- 15.2.16. Johnson & Johnson Services Inc.
- 15.2.17. Merck KGaA
- 15.2.18. Sanofi S.A.
- 15.2.19. Pfizer Inc.
- 15.2.20. Sartorius AG
- 15.2.21. Sutro Biopharma, Inc.
- 15.2.22. Sorrento Therapeutics, Inc.
- 15.2.23. Thermo Fisher Scientific Inc.
- 15.2.24. WuXi AppTec Co., Ltd.
- 15.2.25. Others

16. 360 Degree Analyst View

17. Appendix

17.1. Research Methodology
17.2. References
17.3. Abbreviations
17.4. Disclaimer
17.5. Contact Us

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 3,250

￦ 4,692,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,650

￦ 6,713,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650

￦ 8,157,000

※ 부가세 별도